Clinical Trial Update: PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the biological effects of PEP005 Gel on actinic keratosis using reflectance confocal microscopy; the study is completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• PEP005 Gel (ingenol mebutate)

Snippet

Sponsor: LEO Pharma | Conditions: Actinic Keratosis | Phase 1 | Status: COMPLETED | Results posted: 2015-05-27